Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Insulin Pens
... CAGR of 7.2% over the analysis period 2024-2030. Disposable Insulin Pens, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$11.6 Billion by the end of the ... Read More
-
Metabolic Disorder Therapeutics
... at a CAGR of 6.9% over the analysis period 2024-2030. Diabetes Therapeutics, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$91.9 Billion by the end of ... Read More
-
Smart Insulin Pens and Pumps
... Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Smart Insulin Pumps, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$7.9 ... Read More
-
Diabetic Retinopathy Treatment
... at a CAGR of 5.0% over the analysis period 2024-2030. Non-Proliferative Diabetic Retinopathy, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$7.5 Billion by the end ... Read More
-
Diabetic Shoes
... CAGR of 8.1% over the analysis period 2024-2030. Online Distribution Channel, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$10.6 Billion by the end of the ... Read More
-
Blood Glucose Meters
... at a CAGR of 6.6% over the analysis period 2024-2030. Self-Monitoring Blood Glucose Meters, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$36.8 Billion by the ... Read More
-
Continuous Glucose Monitoring Systems
... 2030, growing at a CAGR of 15.9% over the analysis period 2024-2030. Sensors Component, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$5.4 Billion by the ... Read More
-
Diabetes Drugs
... CAGR of 9.3% over the analysis period 2024-2030. Oral Drugs, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$163.4 Billion by the end of the analysis ... Read More
-
Diabetic Food
... CAGR of 4.8% over the analysis period 2024-2030. Dietary Beverages, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$6.2 Billion by the end of the analysis ... Read More
-
Artificial Pancreas Device Systems
... 2030, growing at a CAGR of 18.8% over the analysis period 2024-2030. Threshold Suspended Device Systems, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$1.2 Billion ... Read More
-
Insulin Pumps
... CAGR of 7.0% over the analysis period 2024-2030. Tethered Pumps, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$15.0 Billion by the end of the analysis ... Read More
-
Diabetic Nephropathy Treatment
... at a CAGR of 4.8% over the analysis period 2024-2030. Angiotensin Receptor Blockers (ARBs), one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.8 Billion by the ... Read More
-
Glucose Monitoring Devices
... at a CAGR of 4.6% over the analysis period 2024-2030. Self-Monitoring Devices, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$11.3 Billion by the end of ... Read More
-
Nocturia Drugs
... CAGR of 6.1% over the analysis period 2024-2030. Low Nocturnal Bladder Capacity Indication, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.0 Billion by the end ... Read More
-
Diabetic Footwear Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Global Medical Case Management Market - 2025 - 2033
... of 6.4% during the forecast period 2025-2033. Medical case management is a systematic approach to managing healthcare services for individuals with complex medical conditions or chronic illnesses. It involves assessing a patient's needs, planning and ... Read More
-
Global Diabetes Drugs Market - 2025 - 2032
... % during the forecast period 2025-2032. Diabetes is a chronic condition that arises when the pancreas either fails to produce sufficient insulin or when the body cannot effectively utilize the insulin it produces. Insulin is ... Read More
-
Global Incretin-Based Drugs Market - 2025 - 2032
... during the forecast period 2025-2032. Incretin-based drugs are a class of antidiabetic medications designed to mimic the effects of incretin hormones, which are naturally produced by the body to help regulate insulin secretion in response ... Read More
-
Pet Diabetes Care Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats), By Solution (Treatment, Glucose Monitoring Devices), By Distribution Channel (E-Commerce), By Region, And Segment Forecasts, 2025 - 2030
... a new report by Grand View Research, Inc. The growing number of companion animals, the high rate of pet adoption, increased spending on pets, and the rising incidence of diabetes mellitus in dogs and cats ... Read More
-
Generic Drugs Market Report by Therapy Area (Central Nervous System, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Retail Pharmacies, Hospital Pharmacies), and Country 2025-2033
... global generic drugs market size reached USD 389.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 674.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.66% during 2025-2033. The ... Read More
-
Biosimilar Market Report by Molecule (Infliximab, Insulin Glargine, Epoetin Alfa, Etanercept, Filgrastim, Somatropin, Rituximab, Follitropin Alfa, Adalimumab, Pegfilgrastim, Trastuzumab, Bevacizumab, and Others), Indication (Auto-Immune Diseases, Blood Disorders, Diabetes, Oncology, Growth Deficiency, Female Infertility, and Others), Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2025-2033
... Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2025-2033 The global biosimilar market size reached USD 26.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 185.1 Billion by 2033, exhibiting ... Read More
-
2025 Global Forecast for Diabetic Footwear Market (2026-2031 Outlook)-High Tech Outlook Report
... or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx billion ... Read More
-
Type 1 Diabetes: 68-Market Analysis and Sales Forecast
... version of the Excel model containing the patient-based forecast (PBF) sales for type 1 diabetes, covered in GlobalData’s report “Type 1 Diabetes: Seven-Market Drug Forecast and Market Analysis”, published in January 2025. In addition to ... Read More
-
2025 Global: Diabetic Macular Edema - Innovative Markets Forecast (2031) report
... forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market research ... Read More
-
2025 Global Forecast for Diabetes Care Devices Market (2026-2031 Outlook)-High Tech Outlook Report
... product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx ... Read More
Research Assistance
